4,718 Shares in Doximity, Inc. $DOCS Bought by JT Stratford LLC

Key Points

• JT Stratford LLC has purchased a new stake of 4,718 shares in Doximity, Inc., valued at approximately $274,000.
• Major hedge funds such as Hsbc Holdings and Wellington Management Group significantly increased their holdings in Doximity during the first quarter, highlighting growing institutional interest.
• Doximity reported a **Q2 earnings** per share (EPS) of $0.36, exceeding analysts' expectations of $0.31, alongside a revenue increase of **15.2%** year-over-year.

JT Stratford LLC acquired a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,718 shares of the company's stock, valued at approximately $274,000.

A number of other institutional investors and hedge funds have also bought and sold shares of DOCS. Hsbc Holdings PLC lifted its holdings in Doximity by 752.1% in the first quarter. Hsbc Holdings PLC now owns 141,191 shares of the company's stock valued at $8,120,000 after buying an additional 124,622 shares during the period. Fuller & Thaler Asset Management Inc. raised its holdings in Doximity by 9.5% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,730,282 shares of the company's stock worth $100,408,000 after buying an additional 150,574 shares during the last quarter. Pinnacle Wealth Management LLC acquired a new position in Doximity during the first quarter worth $581,000. Quantbot Technologies LP raised its holdings in Doximity by 182.6% during the first quarter. Quantbot Technologies LP now owns 212,868 shares of the company's stock worth $12,353,000 after buying an additional 137,541 shares during the last quarter. Finally, Wellington Management Group LLP boosted its holdings in Doximity by 74.9% during the 1st quarter. Wellington Management Group LLP now owns 11,639 shares of the company's stock worth $675,000 after acquiring an additional 4,983 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms have issued reports on DOCS. JPMorgan Chase & Co. cut their price objective on shares of Doximity from $63.00 to $60.00 and set a "neutral" rating on the stock in a report on Tuesday, May 27th. Bank of America upped their price target on Doximity from $55.00 to $62.00 and gave the company a "neutral" rating in a research report on Wednesday, June 25th. KeyCorp upped their price target on Doximity from $65.00 to $70.00 and gave the company an "overweight" rating in a research report on Monday, July 14th. Zacks Research cut Doximity from a "strong-buy" rating to a "hold" rating in a research report on Wednesday. Finally, Mizuho reduced their price target on Doximity from $65.00 to $60.00 and set a "neutral" rating for the company in a research report on Friday, May 16th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $66.21.

Insider Buying and Selling

In related news, Director Kira Scherer Wampler sold 2,000 shares of the company's stock in a transaction on Friday, August 1st. The shares were sold at an average price of $57.09, for a total value of $114,180.00. Following the completion of the transaction, the director directly owned 16,618 shares in the company, valued at approximately $948,721.62. The trade was a 10.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Timothy S. Cabral sold 10,000 shares of the company's stock in a transaction on Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total transaction of $600,000.00. Following the completion of the transaction, the director owned 6,360 shares of the company's stock, valued at $381,600. This trade represents a 61.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 36,000 shares of company stock worth $2,140,940. Corporate insiders own 31.30% of the company's stock.

Doximity Stock Up 5.6%

Shares of DOCS stock traded up $3.5630 on Friday, reaching $67.6930. The company's stock had a trading volume of 1,637,248 shares, compared to its average volume of 2,323,116. Doximity, Inc. has a 12-month low of $35.32 and a 12-month high of $85.21. The company has a market capitalization of $12.68 billion, a P/E ratio of 67.69, a PEG ratio of 4.10 and a beta of 1.36. The stock's 50 day simple moving average is $60.80 and its 200-day simple moving average is $60.48.

Doximity (NASDAQ:DOCS - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same period in the prior year, the firm earned $0.28 EPS. The firm's revenue for the quarter was up 15.2% on a year-over-year basis. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Research analysts expect that Doximity, Inc. will post 0.99 EPS for the current year.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.